Modified immune cells that ruthlessly kill cancerous tumours may prove a game-changer for people living with late-stage cancer.
A novel combination of two forms of immunotherapy can be highly effective for treating lung cancer, McMaster researchers find.
Researchers at McMaster University have invented a stable, affordable way to store fragile vaccines for weeks at a time at temperatures up to 40C, opening the way for life-saving anti-viral vaccines to reach remote and impoverished regions of the world.